At Biotrial, we recognize the transformative impact of Real-World Data (RWD) in advancing clinical research and enhancing patient outcomes. Our comprehensive RWD services are designed to bridge the gap between controlled clinical trials and everyday clinical practice, providing actionable insights that drive informed decision-making throughout the drug development lifecycle.
Real-World Data involves health-related information collected outside the confines of clinical trials. This includes routinely collected data from electronic health records (EHRs), insurance claims, patient registries, as well as secondary use of data from cohort studies or previous clinical trials.
Secondary use of existing data to generate early evidence of treatment efficacy and speed up drug approval
Application of advanced causal inference methods to emulate a target trial from observational data
Leverage public database (e.g., SNDS, PMSI, ESND) to generate insights on disease burden and treatment pathways
Custom designed studies-descriptive or casual – to understand the natural history of disease.
Indirect treatment comparisons using individual or aggregated data (e.g., Matching- adjusted indirect comparison, Network Meta Analysis)
With extensive experience in clinical research and a deep understanding of data analytics, Biotrial is uniquely positioned to harness the power of Real-World Data. Our multidisciplinary team collaborates closely with clients to develop customized RWD strategies that address specific research objectives and regulatory requirements.
Partner with Biotrial to leverage Real-World Data in your clinical development programs, enhancing the relevance and applicability of your research findings, improving patient outcomes, and supporting regulatory decision-making.
